“Site Selection Solutions Using Patient Insights for Rare Disease Trials”

In rare disease trials, site selection decisions made too early—or without patient insight—can lead to delayed enrollment, missed sites, and unrealistic feasibility assumptions.

This live webinar explores how patient-informed landscape analysis strengthens site selection and recruitment planning by combining real-world data, investigator insight, and patient advocacy perspectives—before protocols are finalized.

Live webinar | February 20, 2026
10:00 AM EST | 3:00 PM GMT | 4:00 PM CET
Duration: 60 minutes

What this webinar covers

• How patient-centric intelligence improves early site selection decisions
• A practical three-pillar approach combining data, investigator insight, and patient advocacy engagement
• Identifying centers of excellence, realistic enrollment potential, and site readiness earlier
• Real-world case examples from rare disease trials

Learn how integrating patient insight earlier in landscape analysis leads to more feasible, ethical, and efficient rare disease trials—with stronger enrollment planning and fewer downstream surprises.